Instrument Inactif

Autres langues Pharmacyte Biotech Inc Other OTC

Actions

US67090R1005

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

18/03	PharmaCyte Biotech, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 31 janvier 2024	CI
2023	PharmaCyte Biotech, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 octobre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.	17/06
MyMD Pharmaceuticals, Inc. amended terms of the transaction	23/05
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease	21/05
MyMD Pharmaceuticals, Inc. announced that it expects to receive $14 million in funding from PharmaCyte Biotech, Inc.	20/05
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	18/03
PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	18/03
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	15/12
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	15/12
Femasys Inc. announced that it has received $6.85 million in funding from PharmaCyte Biotech, Inc. and other investors	22/11
Femasys Inc. announces tranche update	17/11
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.	16/11
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	15/11
Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc.	14/11
PharmaCyte Biotech : Change in Certifying Accountants - Form 8-K	10/11
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	31/10/23
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	31/10/23
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology	31/10/23
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	18/09/23
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	18/09/23
PharmaCyte Biotech : Certificate of Incorporation/Bylaws - Form 8-K	07/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pharmacyte Biotech Inc Other OTC

Actions

US67090R1005

Autres langues

Filtres